Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria E Suarez-Almazor

Showing results (231-240 of 243) with videos related to

Pageof 25
Sort By:
The Journal of Rheumatology|August 3, 2011
OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest GroupLaure Gossec, Simon Paternotte, Clifton O Bingham, et al.
Journal for Immunotherapy of Cancer|June 16, 2023
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse eventsFaisal Fa'ak, Maryam Buni, Adewunmi Falohun, et al.
The Journal of Rheumatology|February 3, 2019
OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making InterventionsKarine Toupin-April, Jennifer L Barton, Liana Fraenkel, et al.
JMIR Research Protocols|April 25, 2020
The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility TrialMarie-Eve Carrier, Linda Kwakkenbos, Warren R Nielson, et al.
Pilot and Feasibility Studies|February 27, 2022
Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) ProgramLinda Kwakkenbos, Nora Østbø, Marie-Eve Carrier, et al.
BMJ Open|August 10, 2013
The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease contextLinda Kwakkenbos, Lisa R Jewett, Murray Baron, et al.
Nature Communications|April 13, 2022
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapySang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Nature Communications|July 4, 2024
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapySang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Clinical and Experimental Rheumatology|January 17, 2012
New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN)Brett D Thombs, Lisa R Jewett, Shervin Assassi, et al.
Trials|November 28, 2021
The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trialJulia Nordlund, Richard S Henry, Linda Kwakkenbos, et al.
Pageof 25

Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
The Journal of Rheumatology|August 3, 2011
OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest GroupLaure Gossec, Simon Paternotte, Clifton O Bingham, et al.
Journal for Immunotherapy of Cancer|June 16, 2023
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse eventsFaisal Fa'ak, Maryam Buni, Adewunmi Falohun, et al.
The Journal of Rheumatology|February 3, 2019
OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making InterventionsKarine Toupin-April, Jennifer L Barton, Liana Fraenkel, et al.
JMIR Research Protocols|April 25, 2020
The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility TrialMarie-Eve Carrier, Linda Kwakkenbos, Warren R Nielson, et al.
Pilot and Feasibility Studies|February 27, 2022
Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) ProgramLinda Kwakkenbos, Nora Østbø, Marie-Eve Carrier, et al.
BMJ Open|August 10, 2013
The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease contextLinda Kwakkenbos, Lisa R Jewett, Murray Baron, et al.
Nature Communications|April 13, 2022
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapySang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Nature Communications|July 4, 2024
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapySang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Clinical and Experimental Rheumatology|January 17, 2012
New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN)Brett D Thombs, Lisa R Jewett, Shervin Assassi, et al.
Trials|November 28, 2021
The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trialJulia Nordlund, Richard S Henry, Linda Kwakkenbos, et al.
Pageof 25